ARTBIO, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2021-01-01
- Employees
- 11
- Market Cap
- -
- Website
- https://artbio.com
Phase 0/1 Study of 212Pb-NG001 in mCRPC
Early Phase 1
Completed
- Conditions
- Metastatic Castration-resistant Prostate Cancer
- Interventions
- First Posted Date
- 2023-02-13
- Last Posted Date
- 2023-10-06
- Lead Sponsor
- ARTBIO Inc.
- Target Recruit Count
- 3
- Registration Number
- NCT05725070
- Locations
- 🇳🇴
Oslo University Hospital, Oslo, Norway
© Copyright 2025. All Rights Reserved by MedPath